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P. Eaton), scamperi@ffyb.uba.ar (S.A. Camperi), nbasso@cea b s t r a c tPatagonia's biodiversity has been explored frommany points of view, however, skin secretions of native amphib-
ians have not been evaluated for antimicrobial peptide research until now. In this sense, Pleurodema thaul is the
first amphibian specie to be studied from this large region of South America. Analysis of cDNA-encoding peptide
in skin samples allowed identification of four new antimicrobial peptides. The predicted mature peptides were
synthesized and all of them showed weak or null antimicrobial activity against Klebsiella pneumoniae, Staphylo-
coccus aureus and Escherichia coli with the exception of thaulin-1, a cationic 26-residue linear, amphipathic,
Gly- and Leu-rich peptide with moderate antimicrobial activity against E. coli (MIC of 24.7 μM). AFM and SPR
studies suggested a preferential interaction between these peptides and bacterial membranes. Cytotoxicity as-
says showed that thaulin peptides had minimal effects at MIC concentrations towards human and animal cells.
These are the first peptides described for amphibians of the Pleurodema genus. These findings highlight the po-
tential of the Patagonian region's unexplored biodiversity as a source for new molecule discovery..K
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1. IntroductionDuring the last decades there has been a rapid increase in the num-
ber of antimicrobial peptides (AMPs) described, with N1017 active pep-
tides derived from amphibians (antimicrobial peptide database, APD).
Most of these share common characteristics: they are in general, cation-
ic, amphipathic and with an α-helix secondary structure, although
some peptides with different characters such as negative charges
(Harris et al., 2009) or with different secondary structures (Wang et
al., 2010) have occasionally also been described. All AMPs are expressed
as prepropeptides harboring a conserved signal peptide, an acidic
propiece and a highly variable domain encoding the AMP itself
(Amiche et al., 1999). This last domain is so variable that the combina-
tion of several of these peptides can form a distinctive marker for each
amphibian specie (Jackway et al., 2011). However, within this variabil-
ity, many peptides share common features such that they have been
classified into common peptide families, such as the brevinins
(Morikawa et al., 1992), caerin, dermasemptins (Amiche et al., 1999),
esculetins (Simmaco et al., 1993), magainins (Zasloff, 1987), ocellatins
(Marani et al., 2015), and temporins (Mangoni et al., 2005). Meanwhile,
some peptides with totally novel structures, which belong to no yet-de-
scribed family have also been occasionally described (Leu rich
peptides).
AMPs are important functional molecules in the innate immune sys-
temand they play defensive roles against external risk factors. However,
besides antimicrobial activity, multiple potential applications have been
identified for AMPs such as anticancer (Oelkrug et al., 2015; Wu et al.,
2014; Gaspar et al., 2013; Chu et al., 2015), insecticidal (Smith et al.,
2011), chemotactic (Craik, 2010) antioxidant (Guo et al., 2014), spermi-
cidal (Zairi et al., 2009), wound healing (Mangoni et al., 2016); protease
inhibition (Miller et al., 1989) and neuropeptide function (Pukala et al.,
2006) among others. Moreover, even derivatives of AMPs have shown a
broad range of different applications (Abdel-Wahab et al., 2008;
Chalrabarti et al., 2003; Schulze et al., 2015). It is worth noting also
that several species appear to lack an AMP system or express AMPs
with null or weak antimicrobial activity against human pathogenic bac-
teria, however, when tested, the same peptides showed strong antimi-
crobial activity against species-specific microorganisms demonstrating
adaptation to their living environments (Sun et al., 2015).
This wide natural variation, and the potential industry application of
AMPs suggests that bioprospection of new structures and biological
functions of AMPs from amphibian skin secretions can become a valu-
able tool for the discovery of new molecules.
The Patagonian region has a broad biodiversity with N50 species of
amphibians, all of them unexplored, so it is a promising source of new
peptides. Pleurodema thaul belongs to the Leptodactylidae family,
Leiuperinae (94sp.) subfamily, where only one of the 94 species has
been studied to date (Physalaemus nattereri, ex Eupemphix nattereri),
in which the presence of only two bradykinin precursors were de-
scribed (NCBI access number BKL1 KJ955469, BBN1 KJ955468). None
of the species of the Pleurodema genus has been explored for AMPs
until now. P. thaul (Schneider, 1799) is widely distributed in Chile and
Argentina (Fig. 1A) (Veloso et al., 2010) P. thaul presents a pair of prom-
inent elevated cutaneous dorso-lateral lumbar glands, just posterior to
the sacrum, that may be confused with eyes (Fig. 1C) giving predators
the impression that is a larger animal, which is why it is also known
as “the four eyed frog”. These kind of macroglands contains granular al-
veoli filled with secretions that present toxicity for several microorgan-
isms and vertebrates (de Toledo and Jared, 1989). Histological analysis
of P. thaul suggested a defensive role for the lumbar glands given the
presence of the granular alveoli and the typical distribution of the der-
mal chromatophores, although no study regarding its secretion was
made until now.
The objective of this work was the identification and characteriza-
tion of P. thaul skin AMPs by mRNA isolation, cDNA cloning and se-
quencing. We report the discovery of four new peptides identifiedfrom the skin of P. thaul. The biological activity of the peptides was eval-
uated and a general characterization of the most active peptide was
performed.
2. Results and discussion
2.1. Identification of cDNA encoding peptides
Isolated P. thaul-skin total RNA was reverse-transcribed to AMP
cDNA using specific primers. cDNA was cloned and N30 colonies were
separately grown in liquid media for subsequent plasmid purification.
Sixteen purified plasmids were subjected to PCR amplification, and
the purified fragments were sequenced (Fig. 2A shows nucleic acid
and deduced amino acid sequence of cDNA encoding thaulin-1). Four
de novo sequences were obtained (Fig. 2B). The amino acid sequences
deduced from the cDNA sequences showed a tripartite structure, as ex-
pected (Amiche et al., 1999): a signal peptide, an acidic sequence and
themature peptide at the C-terminus (Fig. 2B). The signal peptide com-
posed of 22 amino acids ended with a Cys residue similarly to other de-
scribed AMPs (Amiche et al., 1999), except for thaulin-4 were a Ser was
present. It is identical to several signal peptides identified in other gen-
era of amphibians, for example dermaseptins B2, of Phyllomedusa
bicolor; DRP-AA3-6 of Agalychnis annae; DRP-PD3-3 of Pachymedusa
dacnicolor; caerin 1.1 of Litoria splendida (Amiche et al., 1999; Jackway
et al., 2011; Nicolas et al., 2003). It has been hypothesized, that this re-
gion may be used as a signal for endoplasmic reticulum membrane
translocation (Brand et al., 2006). The acidic region contained between
22 and 29 amino acids residues and, in three of the four peptides, it ends
with Lys-Arg as most of reported antimicrobial peptides precursors.
However thaulin-1 does not endwith Lys-Arg; nevertheless, this excep-
tionwas also seen in other published AMP (Li et al., 2007). The fourma-
ture identified peptides consisted of a 26, 24, 20 and 13 amino acid
length. Theoretical molecular weight, estimated pI (http://web.expasy.
org/compute_pi/) and total net charge of peptides are presented in
Table 1.
The new peptides were named thaulins following the nomenclature
of antimicrobial peptides proposed by Amiche et al. (2008) and Conlon
(2008a, 2008b). Themost common approach for peptide nomenclature
is to derive the peptide name from the name of the species. The num-
bers 1 to 4 were incorporated to indicate that these are the first AMPs
found in this species, as suggested by some authors (Wang et al.,
2010; Amiche et al., 2008; Conlon, 2008a, 2008b)
2.2. Preliminary activity test
The four thaulin peptides weremanually synthesized and submitted
to a preliminary activity test against E. coli and S. aureus. Only thaulin-1
showed activity against the two strains while thaulin-3 presented a
weaker activity only against E. coli. This could be related with peptide
net charge. Thaulin-1 and thaulin-3 were the only two peptides with
positive net charge, while thaulin-2 has no net charge and thaulin-4 a
negative net charge (Table 1). Based on these results the following anal-
yses were performed only for thaulin-1 peptide, as this presented the
highest antimicrobial action.
2.3. Sequence analysis
Although antibacterial peptides have very low sequence similarity,
recent studies demonstrate that certain residues are preferred over
others in specific spots, particularly at the N and C terminus. Analysis
of the C-terminus of thaulin-1 showed that eleven of the last fifteen res-
idues match with the first three most likely residues observed for anti-
bacterial peptides in each position (Lata et al., 2009) Also, the large
percentage of Leu and Gly in the composition of thaulin-1 agrees with
an observation made by Wang & Zasloff about AMP amino acid
Fig. 1. (A) Pleurodema thaul distribution from the International Union for Conservation of Nature (IUCN). (B) Collection site area (photo by S. Polcowñuk, used with permission). (C)
Photograph of a juvenile P. thaul (photo by F. Jara, used with permission).
Fig. 2. (A)Nucleic acid and deduced aminoacid sequence of cDNA encoding thaulin-1 from the skin of P. thaul. Signal peptide, acidic region andmature peptide are signaled in boxedwhite,
black and gray letters respectively and stop codon is indicated with an asterisk. (B) Alignment of the deduced amino acid sequences of the precursors of thaulin peptides. Preproregions
(signal peptide and acidic regionboxedwhite and black respectively) and variable domain (boxed gray) that correspond tomature peptide are signaled. Cys indicating the end of the signal
peptide are indicated with an asterisk. Processing sites Lys-Arg present in the acidic region are underlined. Gaps (-) have been introduced to maximize sequence similarities.
Table 1
Theoretical molecular weight, estimated pI and total net charge of thaulin peptides.
Name Sequence Mw pI Net charge
Thaulin-1 NGNLLGGLLRPVLGVVKGLTGGLGKK 2531.08 11.26 +4
Thaulin-2 ELLGGLLDPVLGVANALTGGIIKK 2361.85 6.17 0
Thaulin-3 NLVGSLLGGILKK 1311.63 10.00 +2
Thaulin-4 DDGEEAESEAANPEENTVGG 2019.92 3.27 −8sequences, which is that Leu, Gly and Lys are themost frequently occur-
ring amino acids in AMPs from animals (Wang et al., 2010)
The thaulin-1 sequence was compared with the APD database to
look for the most similar peptides. Table 2 summarizes the top five re-
sults. Multiple alignment analysis revealed structural similarity with
two Gly-rich peptides and 3 peptides of the bombinin subfamily
(Table 2).
Thaulin-1 has 30% of Gly and 26% of Leu composition, making
thaulin-1 a Glycine/Leucine-rich peptide. In common with bombinin,
thaulin-1 harbours a PVLGxV motif in the middle of the sequence
(where x-position Val-for-Leu change is a conserved substitution) and
the GGLxKK motif at the C-terminus (where x is a Gly, Ile or Leu).
Further comparisons through other protein databases revealed that
thaulin-1 presents structural similaritywith parts of sequences of bacte-
rial transmembrane proteins. Six of the most similar proteins found by
Blastp are depicted in Table 3. It is noteworthy that the highest similar-
ity belongs tomembrane proteins described in Gram-negativemicroor-
ganisms. The shared region involves a similar sequence that repeats
throughout the molecule a few times. This pattern suggests that the
similar region behaves as a transmembrane helix spanning the lipid bi-
layer, and also supports a potential role of thaulin-1 as a membrane
disruptor. This observation is sustained by secondary structure predic-
tions and atomic force microscope observations.2.4. Secondary structure prediction
Wang and Zasloff hypothesized that abundance of residues in an
AMP sequence may contain structural information. That is that we can
“predict” secondary structure based on amino acid residues content.
They made a statistical analysis of AMPs annotated as “helix” in the
APD (based on NMR and circular dichroism) and found that Leu, Ala,
Gly and Lys residues are the most abundant in contrast with peptides
with known β or αβ structures where Cys, Gly and Arg or Cys and Gly
are abundant residues (Wang et al., 2010)
Thaulin-1 presents 6 Leu, 8 Gly and 3 Lys residues which represent
65% of abundance in their amino acid content.
Three-Dimensional structure prediction of thaulin-1 and Gly-
thaulin-1 showed a central alpha helix structure with ends in random
coil form (Fig. 3C and D). Helix wheel projection demonstrated an ali-
phatic structure; especially when we only considered the residues that
integrate the α-helix in the predicted 3D structure (Fig. 3E and F).Table 2
Thaulin-1 structural similarity with peptides. Boxed black letters represent identical amino ac
Mignogna et al., 1993).
Name Sequence
Thaulin-1 N G N L L G G L L R P V L G V V K G - - L T G
Leptoglycin - G - L L G G L L G P L L G - - G G - - G G G
Maximin H39 - - - I L - G - - - P V L G L V - G N A L - G
Maximin H3 - - - I L - G - - - P V L G L V - G N A L - G
Bombinin H4 - - - - L I G - - - P V L G L V - G S A L - G
Plasticin-S1 - G - L V S D L L S T V T G L L G N L - G G2.5. Peptide synthesis and characterization
Residue composition analysis of thaulin-1 was performed to evaluate
potential difficulties during peptide synthesis as well as to increase the
yields of the process for possible large-scale production. We estimated
that peptides with asparagine (Asn) at the N-terminal position would
present difficulties when removing the N-terminal protecting group
(http://www.sigmaaldrich.com/life-science/custom-oligos/custom-pep-
tides/learning-center/sequence-analysis.html; http://www.biomatik.com
/services/custom-peptide-service/peptide-synthesis.htlm). It is highly
recommended to remove the Asn or substitute it with another amino
acid at the N-terminus; therefore, a thaulin-1 derivativewith an N-termi-
nal Gly named Gly-thaulin-1 was synthesized to characterize and com-
pare it with thaulin-1. Thaulin-1 and its derivative Gly-thaulin-1 were
both manually synthesized and purified by reversed-phase high perfor-
mance liquid chromatography (RP-HPLC). To evaluate purity and molec-
ular mass of thaulin-1 and Gly-thaulin-1, a MALDI-TOF/TOF analysis was
performed resulting in [M+ H]+ of 2531.10 Da and 2588.17 Da, respec-
tively (Figs. S1 and S2). Tandemmass spectrometry (MS/MS) analysis of
purified thaulin-1 and Gly-thaulin-1 corroborates the obtained peptides
sequences. Spectrummeasurements are available in the supporting infor-
mation (Figs. S3 and S4).
2.6. Circular dichroism (CD)
To study the conformational behaviour of thaulin-1 andGly-thaulin-
1, CD analyses were performed in water and TFE solutions of increasing
concentrations. CD measurements in water and 10% of TFE revealed a
random conformationwith aminimum close to 198 nm. As TFE concen-
tration increases, the shape of CD spectra suggests the propensity to
form defined secondary structures. All 40% TFE spectra showed two
minima around 209 and 222 nm, characteristic of α–helix structures
(Fig. 3A). This result could indicate that these peptides are unstructured
(unfolded/linear) in aqueous solution and that they fold into alpha-he-
lices upon interaction with microorganisms, as was previously demon-
strated for other antimicrobial peptides including aurein 1.2 and
magainin 2 and cecropin A using different tools such as Fourier-trans-
form infrared (FTIR) spectroscopy (Seto et al., 2007) and CD (Avitabile
et al., 2014) respectively. The role of peptide self-assembly is considered
as another important property that influences on the activity and mode
of action of peptides such as particular responsiveness, sustained re-
lease, improved selectivity and stability (Tian et al., 2015).
2.7. Antimicrobial assays
Synthetic purified and quantified thaulin-1 and Gly-thaulin-1
peptides showed identical minimal inhibitory concentration (MIC)
and minimal bactericidal concentration (MBC) values (Table 4),
demonstrating that the mechanism of action is mainly bactericide,
not involving a significant inhibitory stage. Both Gram-negative
and Gram-positive strains were tested, and the former were foundid position, and boxed gray letters represent conservative substitutions (Lai et al., 2002;
Similarity 
percentage
(%)
Species Reference
G L G K K - Pleurodema thaul This work
G G G L L - 53,84 Leptodactylus pentadactylus Sousa et al. (2009)
G L I K K L 48,27 Bombina maxima Liu et al. (2011)
G L I K K I 48,27 Bombina maxima Lai et al. (2002)
G L L K K I 48,27 Bombina variegata Mignogna et al. (1993) 
G G L K K I 44,82 Phyllomedusa sauvagei Amiche et al. (2008)
Table 3
Thaulin-1 structural similaritywith internal sequences of proteins. Boxed black letters represent identical amino acid position, and boxed gray letters represent conservative substitutions.
Protein Sequence Species
Similarity 
percentage 
(%)
Thaulin-1 N G N L L G G L L R P - - V L G V V K G L T G G L G K K Pleurodema thaul
Hemagglutinin-related transmembrane protein T G N G E G G L L S P - - V T G L L G G L T G G L G G - Alcaligenes sp. 62
Uncharacterized protein T G N G E G G L L S P - - V T G L L G G L T G G L G G - Achromobacter sp. 62
Membrane protein T G N G E G G L L S P - - V T G L L G G L T G G L G G - Alcaligenes sp. 62
Membrane protein N G S S S G S P A S - N P L T G L L G S L G G A T G G - Burkholderia gladioli 27
bPA24NtDFP W G N L L G G V L G V - S V I G A I V L L T G G M G E - Clostridium sp. 54
Lipoprotein T G N G D G G L L S P - - V T G L L G G L T G G L A G - Alcaligenes faecalis 58
74 M.M. Marani et al. / Gene 605 (2017) 70–80to be more susceptible, showing MIC/MBC values of 62.5 μg/mL and
125 μg/mL for E. coli and K. pneumoniae, respectively. These results
are consistent with the weak antimicrobial activity described for
Leptoglycin, the peptide that present 53.84% sequence similarity
with thaulin-1 (Table 2). Leptoglycin, is Gly/Leu rich AMP isolated
from the skin secretion of the South American frog Leptodactylus
pentadactylus (Table 2) and it was active only against Gram-negative
strains with MIC value for E. coli of 50 μM (Sousa et al., 2009), the
double of the value found for thaulin-1 (MIC 24.7 μM). AccordingFig. 3. Graphical analysis of thaulin-1 and Gly-thaulin-1 peptide structures. Circular dichroism
2,2,2-trifluoethanol (TFE) solutions (red, blue and green respectively). (C) thaulin-1 and (D) G
of complete and α-helix fragment of (E) thaulin-1 and (F) Gly-thaulin-1 sequences. Amino ac
Arg), purple = polar without charge (Thr), pink = polar without charge (Asn), green = Pro.to the Shai-Matsuzaki-Huang (SMH) model of antimicrobial peptide
action (Matsuzaki, 1999; Shai, 1999), a positive net charge is needed
to interact with the bacterial membrane, so that the presence of neg-
atively charged lipopolysaccharides (LPS) in the outer membrane of
Gram-negative bacteria oriented towards the exterior can favor the
interaction of peptides. No difference between the activity, as mea-
sured by MIC and MBC, of thaulin-1 and its analogue Gly-thaulin-1
were observed, indicating that the presence of N-terminal Gly did
not alter antimicrobial performance of thaulin-1.of peptides (A) thaulin-1 and (B) Gly-thaulin-1 in aqueous (black) and 10, 20 and 40% of
ly-thaulin-1 3D structure prediction. Schiffer and Edmundson wheel projection diagrams
id colour code: yellow = unpolar/hydrophobic (Leu, Val), gray = Gly, blue = basic (Lys,
2.8. Antileishmania assays
Thaulin-1 and Gly-thaulin-1 were incubated with amastigote and
promastigote forms of L. infantum to evaluate whether they possess
inhibitory activity or not. We found no activity in the range of 1 to
128 μg/mL (Table S1, Fig. S5).2.9. Cytotoxicity. Hemolytic assays
Thaulin-1 and Gly-thaulin1 peptides were tested in a hemolysis
assay. They showed little activity on human red blood cells (RBCs)
when assessed at concentrations corresponding to E. coli-K. pneumoniae
MIC/MBC (b3.5%). These data indicate that thaulin-1 and Gly-thaulin-1
may have a selective effect towards Gram-negative bacteria cells with
respect to human RBCs. However, at higher peptide concentrations
(500 μg/mL) both peptides present approximately 85% hemolysis,
which may hamper their application against S. aureus (Fig. S6). Once
again, no significant differencewas seen between thewild type peptide,
and the Gly-substituted variant.2.10. Cytotoxicity. cell culture and proliferation assay
Thaulin-1 and Gly-thaulin-1 peptides were tested with BMDM to
evaluate peptide cytotoxicity in the range of 32 to 1024 μg/mL. After in-
cubation for 24 h and as depicted in Table S1, the two AMPs tested
showed low cytotoxicity against BMDM. In fact, both peptides present-
ed 50% cytotoxicity concentrations (CC50) superior to 256 μg/mL (Fig.
S7).2.11. Atomic force microscopy (AFM)
Analysis of images obtained byAFMdemonstrated how thaulin-1 af-
fects E. coli cell morphology on treatment. Fig. 4 shows representative
images of the thaulin-1 morphological alterations on E. coli ATCC
25922 cells, at the 62.5 μg/mL (25 μM) MIC concentration, compared
with untreated cells. Upon treatment we saw considerable changes in
the membrane texture that may be due to a membrane destabilization,
which could induce cell inhibition and death. Unfortunately, this work
does not provide direct evidence that this is themechanism. Cell surface
roughness is ameasure of changes in cell texture. Since native cellmem-
branes tend to be very smooth, increased roughness would be expected
for significant changes in surface texture, providing a way to quantify
such textural changes. An increase in roughness of the treated mem-
branes (mean roughness = 5.05 ± 1.3 nm) was observed when com-
paring treated membranes with controls (mean roughness = 1.66 ±
0.3 nm) as illustrated in Fig. S8. This difference in roughness was also
found to be statistically significant, bymeasuring it over a number of dif-
ferent cells.Table 4
Antimicrobial activity determinations (MIC and MBC) of thaulin-1, from P. thaul, and its
Gly-thaulin-1 analogue.a
Peptide name
S. aureus E. coli K. pneumoniae
ATCC 29213 ATCC 25922 ATCC 700603
MICc MBCb MICc MBCb MICc MBCb
(μg/mL) (μg/mL) (μg/mL) (μg/mL) (μg/mL) (μg/mL)
Thaulin-1 500 500 62.5 62.5 125 125
Gly-thaulin-1 500 500 62.5 62.5 125 125
a Experiments performed in triplicate.
b Minimal Bactericidal Concentration.
c Minimal Inhibitory Concentration.2.12. Surface Plasmon Resonance (SPR)
SPR analysis was performed to evaluate thaulin-1 and Gly-
thaulin-1 affinity for membrane models that differ in lipid composi-
tion (Fig. 5). This and other similar methodologies based in the affin-
ity for different biomembrane models were successfully explored for
other peptides. (Salay et al., 2011; Yu et al., 2015; Bechinger, 2010)
Two membrane models, consisting of 1,2-dimyristoyl-sn-glycero-3-
phosphocholine (DMPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoethanolamine (POPE): 1-palmitoyl-2-oleoyl-sn-glycero-3-
phospho-(1′-rac-glycerol) (POPG) (3:1) lipids were used to simulate
mammalian cell and bacterial membranes, respectively. Phosphati-
dylcholine (PC) is commonly present in membranes of eukaryotic
organisms (de Kroon, 2007) while, despite variations among species,
bacterial membranes tend to contain more lipids with anionic head
groups (Epand and Epand, 2009) The latter group is effectively mim-
icked by use of phosphatidylglycerol (PG) (Fernandez et al., 2012).
Representative SPR sensorgrams are shown in Fig. 5, illustrating re-
sults found using thesemembranes as the stationary phase, upon injec-
tion into the flow cell of the SPR of the two peptides. These were further
analyzed by fitting of this data as described in the methods section, and
the results are reported in Table 5. Thaulin-1 and Gly-thaulin-1 show an
increased affinity for anionic membrane systems, which is an important
fact in considering their use as antimicrobial agents (Table 5).
Thaulin-1 has an affinity constant (KA) approximately three thou-
sand times greater for POPE:POPG than it has for DMPC, indicating a
higher molecular binding strength for this bacterial membrane model
than for the model for eukaryotic membranes. In addition, the “on
rate” constant (ka1) is four orders of magnitude greater for POPE:POPG
than for DMPC demonstrating higher speed in interacting with anionic
membranes.
In the case of Gly-thaulin, while it has the same order of magnitude
of “on rate” constant for DMPC and POPE:POPG, the affinity constant is
again approximately three thousand times higher for POPE:POPG, sug-
gesting a stronger molecular binding for bacterial membranes than for
eukaryotic membranes. It is interesting that the difference found in
ka1 between Gly-thaulin, and the wildtype thaulin was the only signifi-
cant difference in the results we noted between them, indicating that
this substitution affects the kinetics of initial interaction with themem-
branes. However, the affinity itself was unaffected by this substitution,
and all other results point to the two peptides being functionally identi-
cal. Thus we can state that the addition of Gly at the N-terminal do not
impair its antibacterial action, as far as we could determine, while it
simplifies considerably the synthesis of the AMP.
3. Conclusions
This work reports the first four peptides identified from the skin of
the Patagonian frog P. thaul. This represents the first reported study of
AMPs from amphibians from this large region of South America. A me-
ticulous characterization of thaulin-1 was performed. Thaulin-1 is a
new amphipathic, cationic 26-residue Gly- and Leu-rich peptide, with
anα-helix secondary structure. Itsmain antimicrobial activity is against
E. coli. It is noteworthy that thaulin-1 not only showed structural simi-
larity with other AMPs, but also with parts of the sequence of diverse
transmembrane proteins. This observation together with CD results
that demonstrate the influence of the environment in the secondary
structure could be related with a mechanism of action of thaulin-1 in
bacteria death. Environmental conditions could trigger self-aggregation
of thaulin-1 in solution through hydrophobic interactions and this could
be part of themechanism of action of the peptide, perhaps a direct inter-
action with membranes by pore forming or structure destabilization.
This conjecture of amechanismof bactericide action based on alteration
of membrane structures is also supported with the AFM evidence col-
lected from E. coli and SPR affinity constants calculated for bacteria
model membranes. In addition, our cytotoxicity studies demonstrated
Fig. 4. Representative AFM image of the antimicrobial effect of thaulin-1 on E. coli ATCC 25922: (A) untreated; (B) after 24 h of thaulin-1 treatment at the MIC.that thaulin AMPs present acceptable levels of tolerance atMIC concen-
trations on eukaryotic cells, which corresponds with the small affinity
constants found for the thaulins with eukaryotic model membranes.
Even though these results do not suggest suitability study for many
human applications, alternative uses in areas where light/low antimi-
crobial activity is required such as food control, wound healing or
antibiofilm agents should not be disregarded. The latter activity was
predicted using the dPABBs web server (Gupta et al., 2016) where
three of the four thaulins peptides were predicted to be biofilm-active.
Further work will be performed to explore this application.Fig. 5. Representative Surface Plasmon Resonance sensograms obtained for thaulin-1 and Gly-t
bilayers. (C) and (D) POPE:POPG (75:25) supported unilamellar bilayers.4. Materials and methods
4.1. Amphibian collection
One juvenile specimen of P. thaul was collected in a wetland mead-
ow in Llao LlaoMunicipal Park (41°2′S; 71°33′W; 821msnl), San Carlos
de Bariloche, Río Negro, Argentina (Fig. 1B) under the license SADS RN°
006/14. The authors state that all animal manipulation were carried out
in accordance with the ARRIVE guidelines.haulin-1 binding to mimetic membrane models. (A) and (B) DMPC supported unilamellar
Table 5
Association (ka1 and ka2) and dissociation (kd1 and kd2) rate constants obtained from the SPR data, for interaction of thaulin-1 and Gly-thaulin-1 by two membranemodels, and affinity
constant (K) determined by numerical integration using the two-state reaction model.
Peptide name Lipid type
ka1 kd1 ka2 kd2 KD KA
(1/Ms) (1/s) (1/s) (1/s) (M) (1/M)
Thaulin-1 DMPC 6.83 × 103 0.100 0.0070 0.0021 3.53 × 10−3 2.84 × 102
POPE:POPG(3:1) 1.891 × 107 0.081 0.0056 0.0020 1.15 × 10−6 8.71 × 105
Gly-thaulin-1 DMPC 1.099 × 104 0.130 0.0082 0.0022 2.59 × 10−3 3.86 × 102
POPE:POPG(3:1) 1.841 × 104 0.074 0.0063 0.0018 9.02 × 10−7 1.11 × 1064.2. cDNA gene cloning
Total RNA from the dorsal region skin (previously frozen in liquid ni-
trogen and pulverized in a mortar) of a single sample of an anesthe-
tized-with-lidocaine hydrochloride P. thaul was extracted using the
reagent trizol (Invitrogen). Agarose gel and spectrophotometer analysis
techniques were used for quality and quantity analysis of the RNA, re-
spectively. Reactions of 3′RACE were performed for cDNA synthesis
using the M-MLV Reverse Transcriptase (Promega). The first round
was performed by using primer 008-EDdTAP (5′-GACCACGCGTATC
GATGTCGACTTTTTTTTTTTTTTTT-3′). The second round of PCR used
PPS-1A (5′-ATGGCTTTCCTGAAGAAATCTCTTTTCCTTGTACTATTCCTTGG-
3′) as forward primer and 009-EDAP (5′-GACCACGCGTATCGATGTC
GAC-3′) as reverse primer. The cycling parameters were as follow:
1 cycle of 94 °C/120 s, 4 cycles of 94 °C/60 s, 53 °C/60 s and 72 °C/60 s;
35 cycles of 94 °C/30 s, 53 °C/30 s and 72 °C/60 s and 72 °C/420 s. PCR
products were purified using ADN PuriPrep-GP Kit (Highway).
Purified fragments were used in a ligation reactionwith the pCR™4-
TOPO®of the TOPO®TAcloning kit for sequencing (Invitrogen), follow-
ing the manufacturer's instructions. Two microliter aliquots were used
for E. coli DH5α competent cells transfection. Competent E. coli DH5α
cells were prepared and transformed using calcium chloride as de-
scribed by Sambrook and Russel (2001) Following the selection and
growth of bacterial colonies, the resulting plasmids were purified
(Highway) and subjected to sequencing by the BigDye® terminator re-
action (Applied Biosystems), using an ABI 3130 DNA analyzer system
(Applied Biosystems) and universal M13 forward and reverse primers.
Sequences were analyzed using the Lasergene sequence analysis soft-
ware (DNASTAR, Inc.).4.3. Sequence analysis
The peptide sequences obtainedwere comparedwith the 2696 anti-
microbial peptides in the antimicrobial peptide database (Wang et al.,
2016). The program ProtParam (Gasteiger et al., 2005) was used for
computation of physical and chemical parameters (MW, theoretical pI,
instability index, aliphatic index, and grand average of hydropathicity,
GRAVY). TheHeliQuest programwasused to calculate hydrophobicmo-
ments (μH) and helix wheel projections (Gautier et al., 2008; Schiffer
and Edmundson, 1967) Three-dimensional structural model predic-
tions and renderings of the new peptide were obtained using the inter-
net resources PEP-FOLD (Shen et al., 2014) and RasMol (Bernstein,
2000) respectively.
The thaulin-1 sequence was also compared against global protein
databases (GenBank CDS, Protein DataBase, SwissProt, PIR and PR),
under the Blastp algorithm adjusted to short protein sequences. For
this analysis, we dismissed hypothetical proteins. Alignment of best
hits and distance trees were performed using the ClustalX 2.1 software
(Larkin et al., 2007) and visualized by NJPlot.
DNA sequence alignment was performed by Basic Local Alignment
Search Tool (BLAST) engine. Nucleic acid search involved the entire se-
quence of thaulin-1 mRNA as a target query and GenBank, EMBL, DDBJ,
PDBand RefSeq as databases. Scores for best alignmentswere calculated
as the sum of the reward/mismatch penalty, set to 0.66, and the gap
parameters, imposed at the highest value for gap extension. Thirtysequences with higher scores were used to construct a distance tree be-
tween sequences using the Neighbour Joining algorithm. Distance be-
tween sequences used for tree generation predicted expected fraction
of base substitutions per site given the fraction of mismatched bases
in the aligned region (Saitou and Nei, 1987).
4.4. Solid-phase peptide synthesis
Peptides were manually synthesized using a solid-phase approach
using Fmoc/tert-butyl chemistry as previously described (Marani et
al., 2015). Rink amide MBHA resin (Peptides International) was used
for the synthesis of N-terminal amidated peptides. Removal of the
protecting groups and cleavage of peptides from the resin was carried
out with trifluoroacetic acid/triisopropylsilane/water (TFA/TIS/H2O)
(95:2.5:2.5). Cleaved peptides were submitted to ether precipitation
washes and were lyophilized three times prior to purification.
4.5. Reversed-phase high performance liquid chromatography (RP-HPLC)
peptide purification
Peptide purification was performed by preparative RP-HPLC
(Phenomenex columns Kinetex 5 μm C18 50 × 21.20 mm) using a
Shimadzu Prominence instrument. Each peptide was dissolved in
H2O/CH3CN (6:4) and submitted to an RP-HPLC system using a gradient
of CH3CN, starting with H2O/0.1% TFA and rising to 100% CH3CN over
15 min (Marani et al., 2015). The formula (A215 − A225) × 144
(μg/mL) was applied for peptide quantification (Wolf, 1983).
4.6. Peptide characterization. Mass spectrometry analysis
Purity andmolecularmass determination of synthetic peptideswere
performed by using a MALDI-TOF/TOF (UltrafleXtreme, Bruker
Daltonics). The instrument was operated in the positive ion mode and
controlled by the Compass for Flex software, version 1.3 (FlexControl
3.3, FlexAnalysis 3.3, Bruker Daltonics). Five thousand laser shots were
accumulated per spectrum in the mass spectrometry (MS) and tandem
mass spectrometry (MS/MS) modes. One-microliter aliquots of the
chromatographic fractions, dissolved in α-cyano-4-hydroxycinamic
acid matrix solution (1:3, v/v), were applied on a stainless steel plate
and dried at room temperature for 30 min. The peptide monoisotopic
mass was obtained in reflector mode with external calibration, using
the Peptide Calibration Standard for Mass Spectrometry mixture (up
to 4000 Da mass range, Bruker Daltonics). Isolated peptides were sub-
mitted to an automatic sequencer for de novo sequencing using LIFT
mode.
4.7. Peptide characterization. Circular dichroism studies
Secondary structure content was studied by circular dichroism
spectroscopy in the far UV wavelengths, using a JASCO J 815 instru-
ment (Jasco Corp., Tokyo, Japan). The measurements were per-
formed under nitrogen gas flow of 8 L/h at 20 °C temperature,
controlled by a Peltier system (JASCO). Spectra were recorded
between 190 and 260 nm, using a 100 mm cell path length. The pep-
tides were dissolved in either Milli-Q water or 2,2,2-trifluoethanol
(TFE) (10, 20 or 40%) at 100 μM final concentration. The instrument
was set at 50 nm/min scan speed, 1 s response time and 1 nm band-
width. The spectra were converted tomolar ellipticity residue half by
using the relationship: [θ]/θ (10 × c × n × d), where [θ] is the molar
ellipticity (in degrees × cm2 × dmol−1), θ the ellipticity in mill
degrees, n is the number of peptide bonds, c is the molar concentra-
tion, d is the length of the cell in centimeters.
4.8. Antimicrobial activity
Assays were performed using the following bacteria strains: E. coli
ATCC 25922, S. aureus ATCC 29213 and K. pneumoniae ATCC 700603.
All bacterial strains were grown at 37 °C in Mueller-Hinton broth until
the logarithmic phase was reached (1 × 108 colony forming units
(CFU) per mL). Minimal inhibitory concentration (MIC) was defined
as the lowest concentration of peptide that inhibits the visible bacterial
growth after incubation for 24 h at 37 °C in aerobic conditions (absor-
bance lower than 0.05 at 600 nm, in a SpectraMax-190,513 spectropho-
tometer, Molecular Devices). Peptide concentrations ranged from 15.62
to 500 μg/mL and final inoculum concentration was 5 × 105 CFU/mL.
After determining the MIC, Minimal bactericidal concentration (MBC)
was verified seeding 10 μL of the wells that showed results equal to or
greater than the MIC onto Mueller-Hinton Agar (MHA) with the assis-
tance of the Drigalski spatula. After 24 h of incubation at 37 °C, the
MBC was considered the lowest concentration that inhibited growth
of bacterial colonies on the agar. All tests were performed in triplicate
and according to CLSI (2012). Standard antibioticswere used as controls
(meropenem for E. coli and K. pneumoniae and oxacillin for S. aureus).
4.9. Antileishmania assays
Cytotoxicity of thaulin-1 and Gly-thaulin-1 was tested against L.
infantum in promastigotes and axenic amastigotes forms. L. infantum
promastigotes (MHOM MA67ITMAP263) were cultured at 25 °C in
RPMI 1640 Glutamax (Gibco) supplemented with 10% (3/v) heat-
inactivatedd foetal bovine serum (FBS), 50 U mL−1 penicillin, 50 μg/mL
streptomycin, and 20 mM 4-(2-Hydroxyethyl)piperazine-1-ethanesul
fonic acid hemisodium salt (HEPES) pH 7.4 (Sigma). Axenic amastigotes
of the same strainwere grown at 37 °C and 5%CO2, inMAAmediumsup-
plemented with 20% (v/v) iFBS, 2 mM Glutamax (GibcoBRL), and
0.023 mM hemin (Sigma), as described previously (Sereno and
Lemesre, 1997). Parasites were incubated for 24 h in the absence (con-
trol) or presence of 1–128 μg/mL of the peptide. Parasite viability was
then determined by the resazurin assay, adapted from Vale-Costa et al.
(2013) and calculated as the percentage in relation to control cultures.
Data were analyzed with GraphPad Prism 5 software and IC50 (50% in-
hibitory concentration) values determined.
4.10. Cytotoxic analysis. Generation of bone-marrow derived macrophages
(BMDM)
Bone-marrow (BM) cells were isolated by flushing femurs and tibia
of BALB/c mouse with Hank's Balanced Salt Solution (HBSS, Gibco), and
differentiated into BM derived macrophages (BMDM) adapted from a
previously described protocol (Gomes et al., 2008) Briefly, BM cells
were collected, centrifuged and suspended in Dulbecco's Modified
Eagle's Medium (DMEM) supplementedwith 10% iFBS, 1% of Minimum
Essential Media/Non-Essential Amino Acids Solution (MEM),
50 U mL−1 penicillin, 50 μg/mL streptomycin (all from Gibco) (com-
plete DMEMmedium or cDMEM), and 10% L929 cell conditioned medi-
um (LCCM) as source of Macrophage-Colony Stimulating Factor (M-
CSF). BM cells were cultured in Petri dishes for 24 h at 37 °C in a 7%
CO2 atmosphere in order to remove fibroblasts. Nonadherent cells
were then counted, plated in 96-well plates (2.5–3 × 104 cells per
well) and incubated at 37 °C in a 7% CO2 atmosphere. On the 4th and
7th day, cDMEM+ 10%LCCMmedium was renewed. After 10 days the
culture was composed by differentiated macrophages.4.11. Assessment of peptide cytotoxicity over BMDM
Cytotoxicity of peptides was determined in BMDM using a standard
resazurin assay, adapted from Vale-Costa et al. (2013). Cultures of
BMDM were supplemented with the different concentrations of the
test compounds for 24 h. BMDM cytotoxicity was then determined by
the resazurin assay, as in Vale-Costa et al. (2013), and calculated as
the percentage in relation to control cultures to which no peptides
were added. Data were analyzed with GraphPad Prism 5 software and
50% cytotoxic concentration (CC50) values determined.
4.12. Hemolytic activity
The hemolytic activity of the peptides was tested using human red
blood cells (RBCs), collected in EDTA (1.8 mg/mL), washed three
times, and resuspended with sterile saline solution (0.85%). Peptides
were tested at different concentrations (15.62–500 μg/mL) according
to Bignami (1993)withmodifications. Triton-X (0.1% v/v) and saline so-
lution were used as positive and negative haemolysis controls, respec-
tively. The mixtures were incubated for 1 h at 37 °C and centrifuged at
10,000 g for 1 min. The value of absorbance of the supernatant (A)
was measured at 492 nm. The hemolysis percentage was then calculat-
ed as follows:
[(Apeptide – Asaline) / (ATriton – Asaline)] × 100
4.13. Atomic force microscopy
E. coli cells, untreated and treated with thaulin-1 at MIC concentra-
tion (62.5 μg/mL), were tested to evaluate the morphological effects of
thaulin-1 on cell morphology. After incubation for 24 h, samples were
prepared according to Araujo et al. (2015). Thirty-microlitres of the cul-
ture media, containing the MIC-treated or untreated E. coli, was depos-
ited onto a clean glass surface followed by drying in a bacteriological
incubator at 35 °C for 10 min. The samples were then gently rinsed
twice with 1 mL of deionized water to remove salt crystals and dried
again under the same conditions, before AFM analysis. All samples
were prepared at the same time, exposed to the same conditions, and
examinedwithin 8 h of deposition (Eaton et al., 2008). The AFManalysis
was carried out in vibratingmode using a TT-AFM from AFMWorkshop,
equipped with a 50 μm scanner. NSG10 cantilevers (NT-MDT) with a
resonant frequency of approximately 320 kHz were used. Images were
analyzed using Gwyddion software 2.40. Representative images were
shown after examination of multiple areas of each sample and from ob-
tained images we calculated the mean roughness (Rq) with the assis-
tance of software. To compare the means t-test was applied using the
GraphPad Prism ® 5.0 software (GraphPad Software Inc.), a p b 0.01
was considered statistically significant.
4.14. Surface Plasmon Resonance (SPR) analysis
SPR experiments were carried out using a Biacore ×100 analytical
system with a L1 sensor chip (Biacore, Uppsala, Sweden). Prior to use,
the L1 chip surface was washed with a conditioning cycle consisting
on the injection of 3-[(3-cholamidopropyl) dimethylamonio]-1-
propanesulfonate (CHAPS), 20mmol⋅dm−3 followed by running buffer
(HEPES). The interaction of thaulin-1 and Gly-thaulin-1 with the lipid
model membranes was examined at peptide concentrations of 0, 2, 4,
6 and 10 μmol.dm−3 and a distinct SPR cycle was performed for each
peptide concentration tested. Each SPR cycle consisted of the immobili-
zation of the vesicles of 1,2-dimyristoyl-sn-glycero-3-phosphocholine
(DMPC) or 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine
(POPE): 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-rac-glycerol)
(POPG) (3:1) on the L1 chip surfacewith an injection of the vesicles sus-
pension, 1 mmol⋅dm−3 , at a flow rate of 2 μL/min for 45 min. This was
followed by successive injections of runningbuffer (50 μL/min for 100 s)
and NaOH (1 mmol ⋅dm−3) (50 μL/min for 60 s). Stabilization finished
with an injection of running buffer at 5 μL/min for 500 s. After that, pep-
tide solution was injected at a flow rate of 10 μL/min during 100 s
followed by a dissociation time of 10 min. Then the lipid membrane
was removed by a double injection of CHAPS and a double injection of
running buffer, both at a flow rate of 10 μL/min for 2.5 min.
The running buffer contained 20 mM HEPES and 150 mM NaCl
pH 7.4. Lipid vesicles (100 nm) were prepared by extrusion above the
lipid transition temperature (Sousa et al., 2015). Kinetic analyses of
the sensorgrams were performed using the Langmuir, the parallel and
the two-state curve fitting models.
5. Associated content
5.1. Supporting information
This material includes: a distance tree of the most similar mRNA se-
quences using thaulin-1 as a query, MALDI-TOF/TOF MS spectra and
MS/MS spectra analysis to corroborate thaulin-1 and Gly-thaulin-1 se-
quences, cytotoxicity of thaulin-1 and Gly-thaulin-1 to L. infantum and
BMDM cells, hemolysis assays results and mean roughness of the un-
treated and treated with thaulin-1 E. coli cell membranes.
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